HOME >> MEDICINE >> NEWS
Data show new Alzheimer's drug offers hope for broad spectrum of dementia Reminyl shown to be effective in patients with 'mixed'or vascular dementia

London, UK, 19 June 2001- ReminylTM (galantamine), a new treatment for mild to moderate Alzheimer's disease derived from the daffodil, is the first medication of its kind shown to be potentially effective in treating dementia in patients with cerebrovascular disease, such as stroke.

Data from a study presented here today at the XVII World Congress of Neurology show that Reminyl improves memory, orientation and language skills of patients with vascular dementia or a combination of Alzheimer's disease and cerebrovascular disease ("mixed" dementia) for at least 12 months. The results also showed that Reminyl improved or maintained the ability of these individuals to perform normal activities of daily living, such as bathing, dressing and doing housework. However, Reminyl is not yet approved for the treatment vascular dementia.

"This study has the potential to make a real impact on the way dementia is treated throughout the world," says Dr Roger Bullock of the Kingshill Research Centre in Swindon, UK. "If the findings of this study are replicated through further research, physicians will no longer need to hesitate before treating dementia in individuals in whom vascular damage has occurred. Reminyl appears to be effective in treating dementia, whether or not cerebrovascular disease is present."

Dementia is a decline in memory and intellectual abilities that results in a significantly impaired ability to function.1 The most common type of dementia is Alzheimer's disease. However, the second most common type is vascular dementia, which often is triggered by one or more strokes and can be caused by uncontrolled hypertension or diabetes.

World-wide incidence of vascular dementia is estimated at six to 12 cases per 1,000 people more than 70 years of age.2 Many other individuals have a mix of Alzheimer's and cerebrovascular disease. In fact, it is estimated that between 10 and 50 per cent of individuals have either vascular or mixed dementia. Unf
'"/>

Contact: Roseann Ward
roseann.ward@ketchum.com
44-0207-611-3661
Ketchum
19-Jun-2001


Page: 1 2 3

Related medicine news :

1. Chemical decoy shows promise for slowing Alzheimers by acting as decoy
2. Neuronal death and processing of Tau protein in Alzheimers disease
3. Researchers discover link between insulin and Alzheimers
4. New trials for counseling caregivers and patients with Alzheimers begin
5. Marijuana ingredient may stall decline from Alzheimers
6. Drugs used to treat Alzheimers in nursing homes are worsening sufferers illness
7. UT Southwestern doctors track Oklahoma Alzheimers patients via telemedicine
8. Contrary to previous findings, smoking is detrimental to patients with Alzheimers
9. Nanoscale diagnostic sets sights on Alzheimers
10. New test is first step in early detection of Alzheimers disease
11. Older people with the Alzheimers gene find it harder to remember to remember even if healthy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2019)... ... May 16, 2019 , ... Prominent pianist Paul Cardall will ... Franklin Theatre on May 22. Ballard founded O.U.R. in 2013 as the leading organization ... a former Department of Homeland Security Special Agent, leads a team of former CIA, ...
(Date:5/16/2019)... ... May 16, 2019 , ... AdventHealth West Florida Division announced ... in Tampa Bay. Today, the prestigious Leapfrog Group, a national nonprofit health care ... Only about a third of those hospitals received an “A” grade, including seven ...
(Date:5/15/2019)... ... May 16, 2019 , ... Statistical Concepts ... p.m. - 3:00 p.m. EDT, https://www.fdanews.com/statisticalconceptsprocessvalidation , Devicemakers: Are the organizations ... or even maybe … Dan O’Leary is here to help. Dan is FDAnews’s ...
(Date:5/14/2019)... ... ... in Wednesday, May 15 at 7pm for the Healthy Woman Show on WJR 760AM radio ... problems that are embarrassing and inconvenient for women. , “We know how bladder control ... time away from your home. Our goal is to help you stop leaking so ...
(Date:5/14/2019)... ... 2019 , ... The Atlanta Falcons, the Baltimore Ravens and ... the U.S. who rely on HydroWorx aquatic therapy pools to care for their ... healing,” said Timothy McCarthy, Chief Executive Officer for HydroWorx. “Whether it’s for ...
Breaking Medicine News(10 mins):
(Date:5/15/2019)... , ... May 15, 2019 , ... ... announce Gaston County’s success thanks to the Stratodesk/ViewSonic SC-T25 Citrix Ready workspace hub. ... of the joint solution in order to deliver advanced endpoint computing to their ...
(Date:5/15/2019)... ... May 15, 2019 , ... PAINWeekEnd on ... in Rhode Island, will be an educational and exciting program providing busy clinicians ... management of chronic pain. , In Rhode Island, updated regulations intended to ...
(Date:5/15/2019)... PLAINS, N.J. (PRWEB) , ... May 15, 2019 , ... ... her for. Her goal is to help patients achieve optimal dental health while addressing ... excellent care at her office in Cresskill, New Jersey. She offers both general dentistry ...
Breaking Medicine Technology:
Cached News: